Kao Justin C, Liewluck Teerin, Milone Margherita
Department of Neurology, Mayo Clinic, Rochester, MN, USA.
Department of Neurology, Mayo Clinic, Rochester, MN, USA.
J Clin Neurosci. 2018 Jul;53:261-262. doi: 10.1016/j.jocn.2018.04.044. Epub 2018 May 3.
We report a 58-year-old woman with slowly progressive facio-scapulo-peroneal muscle weakness due to congenital nemaline myopathy (NM) caused by a novel ACTA1 mutation (c.118A>G, p.Met271Val). In adult patients, congenital NM should be distinguished from sporadic late-onset nemaline myopathy (SLONM), which is a treatable acquired muscle disease often associated with monoclonal gammopathy or HIV infection. Both congenital NM and SLONM are characterized by the presence of nemaline rods in muscle. The patient's clinical history of difficulty running since childhood and weakness in other family members favored a congenital NM. The type 1 fiber atrophy and clusters of rods in normal size muscle fibers supported the diagnosis of congenital NM and prompted genetic molecular testing, which led to discovery of the novel ACTA1 variant causative of the myopathy.
我们报告了一名58岁女性,因一种新的ACTA1突变(c.118A>G,p.Met271Val)导致先天性杆状体肌病(NM),出现缓慢进展的面肩肱型肌无力。在成年患者中,先天性NM应与散发性迟发性杆状体肌病(SLONM)相鉴别,后者是一种可治疗的获得性肌肉疾病,常与单克隆丙种球蛋白病或HIV感染相关。先天性NM和SLONM均以肌肉中存在杆状体为特征。患者自幼跑步困难的临床病史以及其他家庭成员的肌无力情况支持先天性NM的诊断。1型纤维萎缩以及正常大小肌纤维中的杆状体簇支持先天性NM的诊断,并促使进行基因分子检测,从而发现了导致该肌病的新ACTA1变异体。